260 related articles for article (PubMed ID: 10207642)
1. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
Durfy SJ; Bowen DJ; McTiernan A; Sporleder J; Burke W
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):369-75. PubMed ID: 10207642
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing.
Lerman C; Hughes C; Benkendorf JL; Biesecker B; Kerner J; Willison J; Eads N; Hadley D; Lynch J
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):361-7. PubMed ID: 10207641
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Armstrong K; Micco E; Carney A; Stopfer J; Putt M
JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311
[TBL] [Abstract][Full Text] [Related]
4. A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.
Lehmann LS; Weeks JC; Klar N; Garber JE
Genet Med; 2002; 4(5):346-52. PubMed ID: 12394347
[TBL] [Abstract][Full Text] [Related]
5. Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer.
Lipkus IM; Iden D; Terrenoire J; Feaganes JR
Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):533-9. PubMed ID: 10385144
[TBL] [Abstract][Full Text] [Related]
6. Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation.
Kinney AY; Croyle RT; Dudley WN; Bailey CA; Pelias MK; Neuhausen SL
Prev Med; 2001 Dec; 33(6):543-51. PubMed ID: 11716649
[TBL] [Abstract][Full Text] [Related]
7. The influence of acculturation and breast cancer-specific distress on perceived barriers to genetic testing for breast cancer among women of African descent.
Sussner KM; Thompson HS; Jandorf L; Edwards TA; Forman A; Brown K; Kapil-Pair N; Bovbjerg DH; Schwartz MD; Valdimarsdottir HB
Psychooncology; 2009 Sep; 18(9):945-55. PubMed ID: 19090507
[TBL] [Abstract][Full Text] [Related]
8. Attitudes toward genetic testing in patients with colorectal cancer.
Kinney AY; Choi YA; DeVellis B; Millikan R; Kobetz E; Sandler RS
Cancer Pract; 2000; 8(4):178-86. PubMed ID: 11898257
[TBL] [Abstract][Full Text] [Related]
9. Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility.
Benkendorf JL; Reutenauer JE; Hughes CA; Eads N; Willison J; Powers M; Lerman C
Am J Med Genet; 1997 Dec; 73(3):296-303. PubMed ID: 9415688
[TBL] [Abstract][Full Text] [Related]
10. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups.
Glanz K; Grove J; Lerman C; Gotay C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):329-36. PubMed ID: 10207637
[TBL] [Abstract][Full Text] [Related]
11. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
Hughes C; Gomez-Caminero A; Benkendorf J; Kerner J; Isaacs C; Barter J; Lerman C
Patient Educ Couns; 1997; 32(1-2):51-62. PubMed ID: 9355572
[TBL] [Abstract][Full Text] [Related]
12. Genetic counseling and testing for breast cancer risk in African Americans.
Halbert CH
LDI Issue Brief; 2006 Sep; 12(1):1-4. PubMed ID: 17302016
[TBL] [Abstract][Full Text] [Related]
13. Testing for hereditary breast and ovarian cancer in the southeastern United States.
Miron A; Schildkraut JM; Rimer BK; Winer EP; Sugg Skinner C; Futreal PA; Culler D; Calingaert B; Clark S; Kelly Marcom P; Iglehart JD
Ann Surg; 2000 May; 231(5):624-34. PubMed ID: 10767783
[TBL] [Abstract][Full Text] [Related]
14. Women's decisions regarding management of breast cancer risk.
MacDonald DJ
Medsurg Nurs; 2002 Aug; 11(4):183-6. PubMed ID: 12219430
[TBL] [Abstract][Full Text] [Related]
15. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Jul; 53(27):603-6. PubMed ID: 15254451
[TBL] [Abstract][Full Text] [Related]
16. Awareness and concern about ovarian cancer among women at risk because of a family history of breast or ovarian cancer.
Andersen MR; Bowen D; Yasui Y; McTiernan A
Am J Obstet Gynecol; 2003 Oct; 189(4 Suppl):S42-7. PubMed ID: 14586320
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Thompson HS; Valdimarsdottir HB; Duteau-Buck C; Guevarra J; Bovbjerg DH; Richmond-Avellaneda C; Amarel D; Godfrey D; Brown K; Offit K
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1579-85. PubMed ID: 12496047
[TBL] [Abstract][Full Text] [Related]
18. Attitude towards and factors affecting uptake of population-based BRCA testing in the Ashkenazi Jewish population: a cohort study.
Manchanda R; Burnell M; Gaba F; Sanderson S; Loggenberg K; Gessler S; Wardle J; Side L; Desai R; Brady AF; Dorkins H; Wallis Y; Chapman C; Jacobs C; Tomlinson I; Beller U; Menon U; Jacobs I
BJOG; 2019 May; 126(6):784-794. PubMed ID: 30767407
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
[TBL] [Abstract][Full Text] [Related]
20. Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
Kelly K; Leventhal H; Marvin M; Toppmeyer D; Baran J; Schwalb M
Cancer Control; 2004; 11(4):236-44. PubMed ID: 15284715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
